BiomX Stock (AMEX: PHGE) stock price, news, charts, stock research, profile.
Open | $0.330 |
Close | $0.339 |
Volume / Avg. | 147.368K / 2.640M |
Day Range | 0.320 - 0.354 |
52 Wk Range | 0.187 - 0.855 |
Market Cap | $19.979M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 51 |
Short Interest | 0.37% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BiomX (AMEX: PHGE) through any online brokerage.
Other companies in BiomX’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Galecto (NASDAQ:GLTO) and Lumos Pharma (NASDAQ:LUMO).
The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on Monday, April 22, 2024. The analyst firm set a price target for 2.00 expecting PHGE to rise to within 12 months (a possible 490.32% upside). 5 analyst firms have reported ratings in the last year.
The stock price for BiomX (AMEX: PHGE) is $0.3388 last updated Today at May 17, 2024 at 8:00 PM EDT.
There are no upcoming dividends for BiomX.
BiomX’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for BiomX.
BiomX is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.